Assessment of Cellular and Tissue Characteristics in Lipoaspirates Harvested With the LipoLife System and Stirred by VorFat

Alma Lasers1 site in 1 country3 target enrollmentJuly 21, 2021

ConditionsLaser Assisted Liposuction

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Laser Assisted Liposuction
Sponsor: Alma Lasers
Enrollment: 3
Locations: 1
Primary Endpoint: Average adipose cell cluster size
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Single-center, prospective, open-label study. The study aims to assess the structure and viability of fat collected during the LipoLife liposuction procedure

Registry

clinicaltrials.gov

Start Date

July 21, 2021

End Date

May 1, 2023

Last Updated

3 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Alma Lasers

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Subjects scheduled to undergo abdominal w/wo flanks laser-assisted liposuction surgery and are willing to donate the harvested adipose tissue for the study assessment.
•Between 18 and 70 years of age.
•Estimated fat harvesting of at least 300 milliliters.
•Provided written Informed Consent.

Exclusion Criteria

•Pregnant or intending to become pregnant during the course of study.
•Current smoker.
•Presence of known malignancy.
•Active infection in the treatment area.
•History of autoimmune disorder (e.g., Systemic Lupus Erythematosus \[SLE\]).
•History of connective, metabolic, or atrophic skin disease.
•History of keloid scarring.
•Chronic use (\>7 consecutive days) of anticoagulants (such as aspirin) or NSAIDs within 15 days before enrollment.
•Subjects with immune system diseases.
•Any other reason that in the opinion of the investigator, prevents the subject from participating in the study or compromises the subject safety.